Exeter Leukaemia Fund
Exeter Leukaemia Fund is a UK charity providing integrated transport, counselling, financial grants, accommodation, and complementary therapy support to blood cancer patients and families at the Royal Devon and Exeter Hospital Haematology Centre across Devon and South West England.
- Company typePrivate
- Founded1980
- HeadquartersExeter, United Kingdom
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Exeter Leukaemia Fund does
Exeter Leukaemia Fund (ELF) is a UK registered charity (CIO, charity number 1154727) founded in 1980 by Dr Miles Joyner and registered in 1987, providing integrated patient and family support services to people affected by blood cancer and blood disorders attending the Haematology Centre at the Royal Devon and Exeter (RD&E) Hospital in Devon, South West England. The charity delivers a wraparound service stack covering patient transport (a three-vehicle fleet covering 51,142 miles in 2024), counselling (120 referrals in 2024 via a bank of qualified counsellors), accommodation near the hospital (28 rooms used in 2024), financial grants of £250 or £500 per application, complementary aromatherapy, a Filling Time refreshment kiosk (6,587 drinks served in 2024), one-to-one financial guidance through Citizens Advice, and a free will-writing service via Dunn and Baker Solicitors. ELF also funds hospital equipment (e.g., a £20,000 ultrasound machine for Yarty Ward in 2022) and runs an ELF Fellowships programme for haematology staff continuing professional development, with seven fellowships awarded by 2024.
ELF operates exclusively in the donation-and-fundraising revenue model: all income derives from voluntary gifts by individuals, local businesses, community organisations, and charitable trusts, supplemented by Gift Aid (a 25% HMRC reclaim on eligible UK taxpayer donations) and gifts in Wills, which account for approximately 25% of total income. In 2024, ELF raised £477,870 in funds. The go-to-market is community-led, relying on a small employed team (1-10 staff including Head of Charity Operations, Head of Patient Services, Development Manager, hospital support drivers, patient liaison, and lead administrator) supported by 108 volunteers, an annual events calendar (Summer Tea Party, Exeter 5k Inflatable Obstacle Course, South West Coast 50 Ultra Challenge, Santa Run, corporate World Cup Sweepstake), JustGiving online donations, and CSR partnerships with local businesses (e.g., JMC Group sponsoring the transport fleet).
The charity underwent a restructuring in February 2021 in response to a 30-40% COVID-driven funding shortfall, with leadership transitions continuing into 2026 (new Head of Patient Services Gen Ottaway appointed January 2026; CEO Molly Southwood farewelled February 2026). There is no proprietary technology, no public-facing API, and no AI/ML components; all services are human-delivered within the hospital and surrounding community. Geographic scope is confined to Devon and the wider South West England catchment of the RD&E Haematology Centre.
Exeter Leukaemia Fund firmographics
Firmographics- Name
- Exeter Leukaemia Fund
- Legal name
- Exeter Leukaemia Fund CIO
- Website
- https://elfcharity.org.uk
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Exeter Leukaemia Fund is a UK charity providing integrated transport, counselling, financial grants, accommodation, and complementary therapy support to blood cancer patients and families at the Royal Devon and Exeter Hospital Haematology Centre across Devon and South West England.
- Ownership category
- akta.pro rank
Exeter Leukaemia Fund industry classification
Industry- Product category
- Charitable blood cancer patient support services
- NAICS
- Voluntary Health Organizations (813212), Religious, Grantmaking, Civic, Professional, and Similar Organizations (813), Grantmaking and Giving Services (81321)
- SIC
- Services-Social Services (8300), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
- akta.pro secondary industries
- Hospitals, Clinics & Charitable Healthcare Providers (BPAGACAB), Mental Health & Crisis Support Services (BPAGACAD)
Keywords
Where Exeter Leukaemia Fund is headquartered
LocationHeadquarters
- HQ city
- Exeter
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Exeter Leukaemia Fund business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Others, Marketing or Sales
Revenue model
- Donations and Fundraising: ELF is entirely funded by voluntary gifts from individuals, local businesses, community organisations and charitable trusts. Revenue comes from one-off donations, regular giving via direct debit, corporate donations, community event fundraising, and gifts in Wills which account for approximately 25% of total income.
- Gift Aid: UK taxpayer donations can be increased by 25% through the Gift Aid scheme, where HMRC reclaims basic rate tax on donations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Patient Support Grants available to haematology patients at RD&E Hospital |
| Other | Pay-as-you-go | Donation amounts |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Exeter Leukaemia Fund product offering
Product offeringCore offering
Exeter Leukaemia Fund is a registered UK charity providing direct, free support services to blood cancer and blood disorder patients and their families in Devon, primarily those attending the Royal Devon and Exeter Hospital Haematology Centre. Core services include patient transport, professional counselling, financial support grants (£250-£500), hospital-adjacent accommodation, complementary therapies (aromatherapy), financial and benefits advice, free will writing, NHS staff fellowships, medical equipment funding, and a hospital-based refreshment kiosk.
Product overview
Exeter Leukaemia Fund (ELF) is a charity offering a comprehensive suite of patient and family support services for individuals affected by blood cancer in Devon. The organization provides integrated support through multiple service channels including transport assistance, counselling, financial grants, accommodation, complementary therapies, financial advice, and professional development (Fellowships) for NHS staff. These services are delivered in partnership with the Royal Devon and Exeter Hospital's Haematology Centre and operate as a unified support ecosystem designed to lighten the load for patients from diagnosis through treatment and beyond.
Differentiator
Problem solved
Functional benefit
Products and services
- Patient Transport Service A fleet of three vehicles providing free transport for haematology patients and their family members to and from appointments at the Royal Devon and Exeter Hospital, covering patients from across Devon. The service covered 51,142 miles in 2024.
- Counselling Services Up to six one-hour sessions with qualified counsellors for patients and family members, supporting them through diagnosis, treatment, and bereavement. Delivered via a bank of independent counsellors including support for children and young people. 120 referrals were made in 2024.
- Patient Support Grants Fixed financial grants of £250 or £500 available to patients under the care of a haematologist at the Royal Devon and Exeter Hospital to assist with costs arising from their diagnosis. Decisions are made within two weeks and only one award per household is permitted in any 12-month period.
- Accommodation Service Hotel rooms provided near the hospital for patients receiving treatment and for family members who need to be close to their loved ones during care. 28 accommodation rooms were used in 2024.
- Aromatherapy and Complementary Therapies A complementary aromatherapy and massage therapist visits Yarty Ward twice weekly to provide relaxation for patients undergoing long-term treatment.
- Financial Advice and Guidance One-to-one confidential advice and fast-track support for patients and families, delivered in partnership with Citizens Advice. Covers entitlements, work, money, housing, tax, and healthcare matters. Appointments are delivered at the Haematology Centre by designated representative Peter Mitchell.
- Free Will Writing Service Partnership with Dunn and Baker Solicitors providing free will writing or will review services for ELF patients, family members, volunteers, and supporters.
- ELF Fellowships Programme Fellowships awarded to haematology staff to complete further study, attend conferences, or pursue continuing professional development to improve patient outcomes. Seven Fellowships have been awarded to date.
- Filling Time Kiosk A refreshment kiosk located in the Yarty Ward waiting room, operated by ELF staff and volunteers, serving drinks to patients and family members from 10am-3pm Monday to Friday. 6,587 drinks were served in 2024.
- Equipment Funding Funding for vital medical equipment for Yarty Ward, including ultrasound machines for cannula insertion (e.g., £20,000 in 2022), televisions, fridges for isolation rooms, and fitness equipment for patient rehabilitation.
- Support Groups ELF facilitates patient support groups and family support groups where patients and carers can share experiences and connect with others affected by blood cancer.
Quantifiable outcome
- 51,142 miles travelled by drivers in 2024
- +3 more outcomes
Companies that use Exeter Leukaemia Fund
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Exeter Leukaemia Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Exeter Leukaemia Fund partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- JMC GroupcoreSponsors ELF's fleet of three vehicles used for patient transport services. The transport service covers Devon, helping patients get to and from appointments at the RD&E Hospital Haematology Centre.
- Citizens AdvicecoreELF partners with Citizens Advice to offer one-to-one confidential advice and fast-track support for patients and families, including information on entitlements and issues such as work, money, housing, tax and healthcare. Designated representative Peter Mitchell delivers appointments at the Haematology Centre.
- Dunn and Baker SolicitorscorePartnership with Exeter solicitors offering free will writing and review service to ELF patients, family members, volunteers, and supporters.
- Princesshay Shopping CentreminorExeter shopping centre partnership providing visibility in the heart of the city for Christmas fundraising activities, including Santa visits and Christmas light switching-on events.
- River City ChorusminorLocal choir performing festive entertainments at ELF events including Christmas celebrations.
Scale indicators10 records
Recent moves6 records
Expansion highlights4 records
Exeter Leukaemia Fund competitors and assessment
Company assessmentDirect peers
- Young Lives vs Cancer (formerly CLIC Sargent): UK charity supporting children and young people with cancer (including blood cancers) and their families, offering financial grants and emotional support. Overlaps with ELF's paediatric leukaemia support use cases.
- Children with Cancer UK: UK charity funding research and supporting children with cancer (including leukaemia) and their families. Overlaps with ELF's paediatric blood cancer patient population and family-support services.
- Blood Cancer UK: The UK's primary national blood cancer charity (formerly Bloodwise), funding research and providing patient support for leukaemia, lymphoma, and myeloma. Directly comparable to ELF in disease focus but operates nationally at materially larger scale.
- Anthony Nolan: UK charity supporting people with blood cancer and disorders through stem cell transplantation, donor recruitment, and patient services. Comparable in disease focus and patient-support orientation to ELF.
Broad incumbents
- Cancer Research UK: Largest UK cancer charity focused on research with growing patient information services. Competes with ELF for donations and corporate partnerships in the cancer space.
- Macmillan Cancer Support: UK's largest cancer support charity offering financial guidance, information, and practical support to all cancer patients. Competes for the same donor pool as ELF across Devon/South West.
- Marie Curie: UK charity providing care and support for people with terminal illness including blood cancer, with hospice services and information. Competes for legacy and Wills giving in ELF's donor pool.
Regional players
- Tenovus Cancer Care: Wales-based cancer charity providing support, information, and mobile chemotherapy services. Comparable in regional-charity model and patient-support services to ELF but operates in Wales.
- Leukaemia Foundation (Australia): Australian national charity supporting people living with blood cancer through accommodation, transport, and counselling. Closely comparable service model to ELF (transport, accommodation, emotional support) in a different geography.
- Leukaemia & Lymphoma Society: The largest US-based voluntary health organisation dedicated to blood cancer research, education, and patient services. Comparable in disease focus to ELF but operates in a different geography.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Exeter Leukaemia Fund social profiles
Digital presenceExeter Leukaemia Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exeter Leukaemia Fund leadership team
Management profileNumber of profiles
Profiles7 records
Exeter Leukaemia Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exeter Leukaemia Fund M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exeter Leukaemia Fund
What does Exeter Leukaemia Fund do?
Exeter Leukaemia Fund is a registered UK charity providing direct, free support services to blood cancer and blood disorder patients and their families in Devon, primarily those attending the Royal Devon and Exeter Hospital Haematology Centre. Core services include patient transport, professional counselling, financial support grants (£250-£500), hospital-adjacent accommodation, complementary therapies (aromatherapy), financial and benefits advice, free will writing, NHS staff fellowships, medical equipment funding, and a hospital-based refreshment kiosk.
Is Exeter Leukaemia Fund a public or private company?
Exeter Leukaemia Fund is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Exeter Leukaemia Fund founded?
Exeter Leukaemia Fund was founded in 1980. It employs 1 to 10 people.
Where is Exeter Leukaemia Fund based?
Exeter Leukaemia Fund is headquartered in Exeter, United Kingdom, in the Europe region.
How does Exeter Leukaemia Fund make money?
Two revenue lines are on record. Donations and Fundraising is the primary driver. The others are gift Aid.
Who are Exeter Leukaemia Fund's main competitors?
Direct peers on record are Young Lives vs Cancer (formerly CLIC Sargent), Children with Cancer UK, Blood Cancer UK and Anthony Nolan. Broad incumbents are Cancer Research UK, Macmillan Cancer Support and Marie Curie. Regional players are Tenovus Cancer Care, Leukaemia Foundation (Australia) and Leukaemia & Lymphoma Society.
Does Exeter Leukaemia Fund have an API?
No public API is recorded for Exeter Leukaemia Fund.
What industry is Exeter Leukaemia Fund in?
Exeter Leukaemia Fund's product category is Charitable blood cancer patient support services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGACAB, Hospitals, Clinics & Charitable Healthcare Providers. Its NAICS code is 813212 and its SIC code is 8300.